Randomized Clinical Study of Temporary Transvenous Phrenic Nerve Stimulation in Difficult-to-Wean Patients.

Dres, Martin; de Abreu, Marcelo Gama; Merdji, Hamid; Müller-Redetzky, Holger; Dellweg, Dominic; Randerath, Winfried J; Mortaza, Satar; Jung, Boris et al. · Am J Respir Crit Care Med · 2022

rct · Level II

Where this comes from

Abstract

<b>Rationale:</b> Diaphragm dysfunction is frequently observed in critically ill patients with difficult weaning from mechanical ventilation. <b>Objectives:</b> To evaluate the effects of temporary transvenous diaphragm neurostimulation on weaning outcome and maximal inspiratory pressure. <b>Methods:</b> Multicenter, open-label, randomized, controlled study. Patients aged ⩾18 years on invasive mechanical ventilation for ⩾4 days and having failed at least two weaning attempts received temporary transvenous diaphragm neurostimulation using a multielectrode stimulating central venous catheter (bilateral phrenic stimulation) and standard of care (treatment) (<i>n</i> = 57) or standard of care (control) (<i>n</i> = 55). In seven patients, the catheter could not be inserted, and in seven others, pacing therapy could not be delivered; consequently, data were available for 43 patients. The primary outcome was the proportion of patients successfully weaned. Other endpoints were mechanical ventilation duration, 30-day survival, maximal inspiratory pressure, diaphragm-thickening fraction, adverse events, and stimulation-related pain. <b>Measurements and Main Results:</b> The incidences of successful weaning were 82% (treatment) and 74% (control) (absolute difference [95% confidence interval (CI)], 7% [-10 to 25]), <i>P</i> = 0.59. Mechanical ventilation duration (mean ± SD) was 12.7 ± 9.9 days and 14.1 ± 10.8 days, respectively, <i>P</i> = 0.50; maximal inspiratory pressure increased by 16.6 cm H<sub>2</sub>O and 4.8 cm H<sub>2</sub>O, respectively (difference [95% CI], 11.8 [5 to 19]), <i>P</i> = 0.001; and right hemidiaphragm thickening fraction during unassisted spontaneous breathing was +17% and -14%, respectively, <i>P</i> = 0.006, without correlation with changes in maximal inspiratory pressure. Serious adverse event frequency was similar in both groups. Median stimulation-related pain in the treatment group was 0 (no pain). <b>Conclusions:</b> Temporary transvenous diaphragm neurostimulation did not increase the proportion of successful weaning from mechanical ventilation. It was associated with a significant increase in maximal inspiratory pressure, suggesting reversal of the course of diaphragm dysfunction. Clinical trial registered with www.clinicaltrials.gov (NCT03096639) and the European Database on Medical Devices (CIV-17-06-020004).

Medical subject headings